This trial is testing whether using a CGM to help calculate meal-time insulin doses leads to better blood sugar management for people with CF than the current standard method.
1 Primary · 2 Secondary · Reporting Duration: 2 weeks
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Insulin · No Placebo Group · Phase 4
Age 18 - 80 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: